ELIZABETH RUDOLPHI: Open Payments
NPI 1922425735 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 23 payments from 13 companies in 2025. Trend: 2023 $126 · 2024 $380 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $151 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Lundbeck LLC | 2 | $38 |
| Astellas Pharma US Inc | 1 | $33 |
| Lilly USA, LLC | 2 | $28 |
| KYOWA KIRIN, INC. | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: REXULTI, FARXIGA, Veozah, MOUNJARO, CRYSVITA, BREZTRI, YUPELRI, EVENITY.
Industry payments across NM — which companies pay providers there.
